Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q1 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Ekso Bionics' First Quarter 2024 Financial Results Call. At this time, all participants are in a listen-only mode.
Ekso Bionics Holdings Inc. (EKSO)
Market is closed
News
- Displaying 9
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q4 2023 Earnings Call Transcript
Ekso Bionics Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.22 EPS, expectations were $-0.11.
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q3 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Ekso Bionics Quarter Three 2023 Financial Results Call. At this time all participants are in a listen-only mode.
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q2 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Ekso Bionics Q2 2023 Financial Results Conference Call and Webcast [Operator Instructions]. As a reminder, this conference is being recorded.
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q1 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Ekso Bionics First Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q4 2022 Earnings Call Transcript
Operator: Greetings, and welcome to the Ekso Bionics Fourth Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Is Ekso Bionics Holdings, Inc. (EKSO) A Good Stock To Buy Now?
In this article you are going to find out whether hedge funds think Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) is a good investment right now.
Should You Buy Ekso Bionics Holdings, Inc. (EKSO)?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities...
Hedge Fund and Insider Trading News: Sahm Adrangi, Bernard Selz, Stryker Corporation (SYK), VBI Vaccines Inc (VBIV), and More
Kerrisdale Capital, the US hedge fund that made a public enemy of Neil Woodford after shorting two of his prominent holdings, is no longer making bets against companies backed by the embattled UK stock...
Billionaire Hedge Funds
